turn corner rais pt strong result
valuat fair
rais est pt strong result lower volum
elast encourag drive org sale expect sequenti eas
key input creat favor margin setup pocket challeng remain
commentari broad-bas demand bode well multi-national co yet report
reiter hold valuat appear reason ntm price-to-earnings disc hpc
strong result volum elast favor anticip
org sale better expect vs street volum declin
better fear price hit market addit margin trend
appear bottom pricing/force/restructur larg off-set inflationari input
cost gm bp yoy vs bp net ep cleanli beat street
increment restructur save expect moder price demand
eas input cost pressur encourag reiter guidanc appear
achiev solid start year newli appoint ceo mike hsu
guidanc reiter monitor price environ
reiter outlook call org sale growth incl least
price ii adj ep in-lin street expect come
print ep estimate move high end rang
org sale modestli guidanc view conserv given
strong start year manag acknowledg solid progress remain
balanc outlook compani monitor price elast competit
respons character org sale guidanc reason point
takeaway confer call
em price major brand competitor gener move in-lin price increas
local competit follow ii babi care price still suppress
china heard potenti competitor product introduct price
competit south korea pick given continu pressur declin birth
rate iii privat label monitor increas na bath tissu price move
yet iv consum demand broad improv across rang market
quarter includ us brazil asean uk europ india
rais estim pt remain sidelin valuat appear reason
rais ep est take pt re-rat
hpc group eas margin pressur warrant higher multipl stock
howev ntm price-to-earnings discount hpc group averag reason
compar discount past year pt base
ev/ulfcf price-to-earnings impli trade similar discount hpc averag
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
see limit option seller buyer
signific categori overlap global
us
portfolio lead brand gener strong market
manag track record drive margin/ro
organ sale growth
em mix unlik recov near-term
bp oper margin expans given price
increas bp vs bp target
price target base multipl
em acceler bp note growth prior cycl
bp margin upsid product benefit
bp margin upsid commod turn deflationari
price target base multipl
bp top-line volum downsid deterior
em well deceler dm
bp margin downsid increas invest
bp margin downsid greater commod pressur
price target base multipl
pleas see import disclosur inform page report
financi summari market data
estim valuat
pleas see import disclosur inform page report
ep vs lower
expect demand elast strong price
higher phase restructur save
drove strong qtr
reiter guid includ org
sale ep vs street
sale growth net sale declin driven organ growth includ
least price headwind fx reiter
oi growth incl drag translat fx neg transact fx
interest expens expect increas somewhat yoy reiter
save restructur
effect tax rate reiter
capital-expenditure reiter
share repurchas reiter
pleas see import disclosur inform page report
estimate actual million except product research incom expens profit incom incom equiti non-controlling incom attribut dilut continu compositionorgan sale bpsnet bpsfx bp sale bpsmargin analysisgross bpsoper bpsebitda bpstax bp equiti research
thesi chart
chart organ sale growth target
level reason compar estim
base growth na flat growth develop
market growth emerg market in-lin
chart kmb em growth tepid ex argentina price
well double-digit growth prior cycl
chart pressur growth algorithm em
contribut bp org sale growth
chart challeng environ forecast
assum fx-neutral oi growth slow
chart given headwind input cost fx competitive/
privat label pressur averag growth modest
pleas see import disclosur inform page report
organ sale growth vs medium-term targettot two-year average develop average downsidejef forecastem organ sale organ sale growthjef estimate prior cycl organ sale growth algo base em/dm contribut organ sale growth org salescontribut org sale fx neutral oi growth oi growthorg sale salesgrowthebitda conversionul salesev/ul vs stapl peer -key metricsstapl peer average nielsen result period end
chart four-week quarterli sale growth
nielsen xaoc jefferi note nielsen definit may differ compani defin
pleas see import disclosur inform page report
quarterli sale growth sale growth yoy sale growthtwo-year averag sale growthxaoc ckimberli clark mixlatest sale chg vs yageq sale chg vs yagavg eq price chg vs yagdollar share pt chg vs yageq share pt chg vs yag sold promo pt chg vs yag us market share dashboard
chart sale growth vs industri growth left portfolio gain market share right
pleas see import disclosur inform page report
us track channel growth vs industri weight industri growthkmb sale portfolio gain valu share trail averagetrail ltm averag equiti research
factset jefferi note factset consensu estim use non-cov compani
factset jefferi note factset consensu estim use non-cov compani
factset jefferi note factset consensu estim use non-cov compani
pleas see import disclosur inform page report
